Category: Finance
-
Small Business Grant Funds Blood-Brain Barrier Model
A spin-off company from University of Washington is developing a chip device emulating the blood-brain barrier that prevents many drugs from treating neurological disorders.
-
University Spins Off Educational Robot Start-Up
A start-up enterprise spun-off from Harvard University is developing a learning system with robotics to teach computer coding to students.
-
Genomics Company Acquires Open-Source Biomedical Platform
A company providing whole genome analysis is acquiring an enterprise developing open-source computational software for biomedical uses, such as precision medicine.
-
Gene Editing, Therapy Company Gains $83.5M in Venture Funds
A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round.
-
Synthetic Beating Heart Repair Tissue Being Developed
A bioengineering team is developing a synthetic patch that contracts and sends electrical signals to repair heart muscle tissue after a heart attack.
-
Engineered Viruses Studied to Improve Plant Traits.
A research study funded by the U.S. Department of Defense is investigating genetic alterations of plant viruses for delivery of genes to quickly protect corn crops against threats like pests and drought.
-
S&P 500 Tech Stocks Surpass Dot-Com Peak
On Wednesday, Standard & Poor’s index of 500 stocks in the information technology industry closed at 992.29, its highest point since March 2000, at the height of the dot-com boom, when the index reached 988.49.
-
Calif. Agency Supporting Late Stem Cell Trial for ALS
California’s agency supporting stem cell research for regenerative medicine is helping fund a clinical trial testing stem cell treatments for amyotrophic lateral sclerosis, or ALS.
-
Grant Funding Automated Genome Editing System
A consortium of companies and university in the U.K. and U.S. are developing an automated desktop genome editing system using the emerging Crispr technique.
-
Start-Up Applying Artificial Intelligence to New Drug Uses
A new enterprise is being formed to apply artificial intelligence to connect drugs in development to treatments for rare diseases and other unmet medical needs.